, Volume 22, Issue 6, pp 381-388
Date: 23 Aug 2012

Forum

  • show all 0 hide

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access
This is an excerpt from the content

Contents

  • Abstract

  • 1. US FDA Consolidating Drug Safety Info on Single Web Page

  • 2. One in Four Biologicals Subject to Safety Actions Postapproval

  • 3. The Declaration of Helsinki —A Fresh Approach Required?.

  • 4. UKPRI “a Missed Opportunity” says Lancet Editorial

  • 5. Greater Co-Payment Incentives Needed for Use of Generics

  • 6. Hanover Consensus Spurs Debate, Not Consensus, in Germany

  • 7. Reimbursement in Canada —Time to Rethink the Evidence?

  • 8. Potential Candidates to Head Up FDA Considered

  • 9. Pharma Companies Pulling the Strings in Clinical Research

  • 10. Storm over Statins May Make People Think, say Harvard Profs

  • 11. Complex Systems versus Reductionism?

  • 12. Call for National and International Clinical Trial Registries

  • 13. The Challenges of Foreign Clinical Data Approval in Europe

  • 14. Evidence-Based Medicine: Beyond the RCT

  • 15. YouTube —The Future of Public Health Outreach?

  • 16. Can Clinical Research Ever Be Truly Independent?

  • 17. New Method for Evaluating Clinical Evidence Needed

  • 18. New Research Collaboration For ...